Bio-Inova Life Sciences International Report issue

For profit Phase 4
Founded: Paris France (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2002
NCT00163202
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

atorvastatin (lipitor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arteriosclerosis (Phase 4)

Coronary Artery Disease (Phase 4)

Hypercholesterolemia (Phase 4)

Myocardial Ischemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1